Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services will not update the overall hospital quality star ratings at Hospital Compare in January to allow time to review public comment and finalize proposed changes to the star ratings methodology, the agency announced.
Adam Myers, M.D., population health chief at Cleveland Clinic, talks with Nancy Foster, AHA vice president for quality and patient safety, about preventing flu and treating chronic diseases during the pandemic.
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns released new resources, including new sample social media messages and graphics that hospitals and health systems can use to reiterate the importance…
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has released guidance on considerations for health care providers exploring high-flow nasal cannula therapy, a less-invasive oxygen therapy than mechanical ventilation that has shown…
The Department of Health and Human Services will host an additional webinar Nov. 13 at 1 p.m. ET on the Centers for Medicare & Medicaid Services’ Oct. 6 guidance on COVID-19 data reporting requirements for hospitals that participate in Medicare.
The AHA is accepting applications through Dec. 8 for its 2021 Carolyn Boone Lewis Equity of Care Award, which recognizes hospital efforts to reduce health disparities and advance diversity and inclusion.
Join AHA and AVIA for a Health Equity and Diversity Week discussion about addressing health care disparities.
The Food and Drug Administration released final guidance for pharmacies, federal facilities and outsourcing facilities that compound or repackage drugs or mix, dilute or repackage biological products.
The American Medical Association announced Current Procedural Terminology codes for reporting on medical claims two COVID-19 vaccines and their administration to patients by dose.
The Centers for Medicare & Medicaid Services announced Medicare coverage for monoclonal antibody therapies, with no beneficiary cost-sharing for the duration of the COVID-19 public health emergency. CMS said the coverage will apply to bamlanivimab, the Lilly therapeutic that earned an emergency…